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Abstract--1. The action of N-2'-chloroethyl-N-ethyl-2-methyl benzylamine (xylamine) on rat pineal gland 
sympathetic innervation was examined. 
2. This alkylating agent caused a concentration-dependent increase in pineal gland N-acetyltransferase 
(NAT) activity in neurologically intact pineal glands that was suppressed in glands previously subjected 
to bilateral superior cervical ganglionectomy. 
3. Xylamine-induced elevations in NAT activity were attenuated by ]Lnoradrenergic antagonist drugs 
but not by ~t-noradrenergic antagonist drugs. 
4. Since pineal gland uptake of radiolabelled norepinephrine (NE) was impaired by xylamine, the drug 
may increase pineal gland NAT activity by inhibiting NE reuptake into the presynaptic nerve terminal, 
thereby increasing the amount of the neurotransmitter available to stimulate pinealocyte 
fl-noradrenoceptors. 
INTRODUCTION 
Xylamine (N-2'-chloroethyl-N-ethyl-2-methyl ben- 
zylamine) appears to be an irreversible inhibitor of 
neuronal norepinephrine (NE) uptake in both 
central (Dudley et al., 1981) and peripheral nerves 
(Cho et al., 1980; Fischer and Cho, 1982; Ransom et 
al., 1984, 1985). The aziridinium ion, resulting from 
the intramolecular cyclization of xylamine, is believed 
to mediate this inhibitory effect on neuronal uptake 
by alkylating the NE uptake carrier molecule 
(Ransom et al., 1982, 1984). A great deal has been 
learned recently about the neurochemical bases of 
xylamine-induced alterations in noradrenergic neuro- 
transmitter mechanisms, but relatively little is known 
about the possible functional consequences of these 
actions. 
The present experiments were undertaken to study 
the possible functional effects of xylamine on a set of 
well-characterized noradrenergic synapses known to 
influence the synthesis of the pineal gland hormone 
melatonin. The pineal gland enzyme, serotonin 
N-acetyltransferase (NAT; EC 2.3.1.5) plays an 
important role in the formation of  melatonin. 
Norepinephrine molecules released from post- 
ganglionic, sympathetic neurons innervating the 
pineal gland enhance the activity of NAT via 
stimulation of a fl-noradrenoceptor linked, cyclic 
AMP dependent mechanism (Axelrod, 1974). 
Pharmacological manipulations, including those 
involving such well known noradrenergic neuro- 
transmitter uptake inhibitors as desmethylimip- 
ramine and amphetamine, that increase synaptic NE 
levels, elevate pineal gland NAT activity (Axelrod, 
1974; Klein, 1979; Reiter, 1981). In the present 
experiments we determined whether xylamine might 
also increase pineal gland NAT activity via nor- 
adrenergic mechanisms similar to those known to be 
important for other indirectly acting noradrenergic 
neurotransmitter agonists. 
MATERIALS AND METHODS 
Animals 
Male Sprague-Dawley albino rats, weighing 250-350 g, 
were either purchased from Charles River Breeding Labora- 
tories (Wilmington, MA) or bred and reared in our animal 
colony. Animals were housed in groups of 5-6 in hanging 
wire cages, given ad libitum access to tap water and labora- 
tory chow (Ralston Purina, St Louis, MO), maintained 
under 22-23°C ambient temperature conditions at 55% 
relative humidity, and exposed to a 12:12hr light:dark 
cycle (lights on at 0700 hr; incandescent illumination was 
approx. 32 Ix during the light phase). 
All experiments were conducted during the middle of the 
light phase of the cycle. Animals were killed by decapitation 
and pineal glands were excised within 1-2 min. Pineal glands 
were immediately placed in BGJb Fritton-Jackson culture 
medium (Grand Island Biological Co., Grand Island, NY) 
and blood vessels and connective tissue were removed with 
the aid of a dissection microscope prior to in vitro culture. 
Chemicals 
Xylamine HCI was synthesized as described by Kammerer 
et al. (1979). A 100#M solution of xylamine HCI was 
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prepared in 10 mM sodium phosphate buffer (pH 7.4) and 
allowed to stand at least 30 min at room temperature prior 
to use. Yohimbine HCI was purchased from Sigma Chem- 
ical Co. (St Louis, MO), and all other drugs used in these 
experiments were generously provided by the following 
companies: prazosin HCI (Pfizer Inc., Groton, CT); des- 
methylimipramine HC1 (DMI; Revlon Health Care Group, 
Tuckahoe, NY), butoxamine HCI (Burroughs Wellcome 
Co., Research Triangle Park, NC) and practolol HC1 
(Imperial Chemical Industries Ltd, Alderley Park, Cheshire, 
England). 
Effect o f  xylamine on pineal gland and N A T  activity 
For in vitro experiments, pineal glands were placed in 
organ culture using a modification (Altar et al., 1983) of the 
method of Parfitt et al. (1976). In brief, pineal glands were 
preincubated for 30 rain in 247 #1 of incubation medium at 
37°C in a 95:5 O: :CO2 atmosphere. 13 #1 of either vehicle 
or one of several different concentrations of the drug were 
added to the incubation medium and 4 hr later glands were 
frozen and stored at -70°C. 
Pineal gland NAT activity was measured using the proto- 
col described by Altar et al. (1983) based on the method of 
Deguchi and Axelrod (1972). Changes in pineal gland NAT 
activity, calculated as the nmoles of N-acetyltryptamine 
formed per pineal per hr, were analyzed using analysis of 
variance followed by post hoc Student's t-test. 
Effect o f  xylamine on N A T  activity in denervated pineal 
glands 
In order to determine whether the possible xylamine- 
induced alterations in NAT activity were mediated by pre- 
or post-synaptic mechanisms, pineal glands obtained from 
denervated or neurologically intact animals were incubated 
with vehicle or xylamine. Denervations were accomplished 
by bilateral superior cervical ganglionectomies (SCGX) 
performed under ether anesthesia 7 days prior to placing the 
glands in organ culture. Successful removal of the ganglia 
was assessed in vivo by the appearance of ptosis. 
Xylamine inhibition o f  [3H]NE uptake 
Previous studies indicated that xylamine effectively blocks 
neuronal reuptake of NE (Cho et al., 1980; Ransom et al., 
1985). We determined whether xylamine might affect nor- 
epinephrine uptake by using a modification of the method 
of Bowers et al. (1984). Briefly, pineal glands were placed 
in organ culture and eoincubated with vehicle, 100#M 
xylamine, or the well-known NE reuptake inhibitor 
DMI (I00pM). After a 1 hr preincubation period glands 
were transferred to wells containing 1.2 × 10-TM 
[3H]-l-norepinephrine (specific activity = 19.7 Ci/mmol, 
New England Nuclear Corp., Boston, MA) as well as the 
appropriate drug or vehicle solution. At the end of the 
15 rain incubation period the glands were washed in Earle's 
salt solution, and the amount of [3H]NE in the glands was 
determined by liquid scintillation spectrometry. 
Blockade o f  xylamine-induced increase in N A T  activity 
In addition to the importance of #-noradrenoceptor 
stimulation for pineal gland NAT activity, ~-noradreno- 
ceptors may also play a permissive role in the noradrenergic 
induction '6f the enzyme (Klein et al., 1983; Alphs and 
Lovenberg, 1984). In order to more precisely characterize 
the receptor subtype which might mediate xylamine-induced 
changes in NAT activity, pineal glands were coincubated 
with xylamine and 100ttM practolol HCI or butoxamine 
HC1 (#r and fl2-noradrenoceptor antagonist drugs, re- 
spectively) or prazosin HC1 or yohimbine HC1 (~r and 









Fig. I. Effect of xylamine on in vitro NAT activity in intact 
or SCGX denervated pineal glands placed in organ 
culture. All values are means (_SEM)  (N =4-5 
animals per group). The left panel represents the number 
of nmole acetyltryptamine/pineal gland/hour in intact 
rats (*P <0.02; **P <0.01; ***P <0.001 compared to 
intact vehicle treated control animals). The right panel 
represents acetyltryptamine formation in pineal glands from 
bilaterally superior cervical ganglionectomized (SCGX) rats 
(***P <0.001 as compared to intact xylamine treated 
animals). 
RESULTS 
Xylamine caused a concentration dependent in- 
crease in pineal gland N A T  activity (Fig. 1). At  the 
lowest concentration tested ( 5 ~ M )  xylamine pro- 
duced a 2-fold increase in N A T  activity whereas at its 
highest concentration (100~M) the activity o f  the 
enzyme was elevated 77-fold. Al though xylamine 
increased N A T  activity in neurologically intact pineal 
glands, its in vitro action was substantially attenuated 
in pineal glands obtained from animals previously 
subjected to SCGX (Fig. 1). 
Neurologically intact pineal glands took up 
approximately 0 .30pmol  of  [3H]NE from the 
incubation media during the 15min test period. 
Interestingly, both xylamine and D M I  caused an 
80-90% inhibition of  [3H]NE uptake into these 
glands (Fig. 2), 
When administered alone none of  the ¢- or 
#-noradrenoceptor  antagonist  drugs produced any 
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Fig. 2. Effects of xylamine or DMI on in vitro pineal gland 
[3H]NE uptake. Pineal glands were incubated with [3H]NE 
for 15 min in the presence of vehicle, xylamine or DMI. All 
values are mean NE uptake (+SEM) (N = 5 animals per 
group; ***P < 0.001 compared to vehicle treated control 
animals). 
Xylamine induced increase in pineal NAT activity 
Table 1. Effects of ~- or ~-noradrenoceptor antagonist drugs on 
xylamine induced increases in pineal gland NAT activity 
NAT activity (nmol/pineal/hr) 
Drug conditon Vehicle Xylamine 
Vehicle 0.02 _+ 0.01 2.24 _ 0.05* 
Praetolol 0.02 _ 0.01 0.07 + 0.02? 
Butoxamine 0.02 + 0.01 0.29 + 0.06*? 
Prazosin 0.01 + 0.01 2.34 +_ 0.60* 
Yohimbine 0.01 ___ 0.01 2.19 __. 0.63* 
Pineal glands (N = 4 per group) were coincubated with either 
vehicle or xylamine (1001tM) and a- or /~-noradrenoceptor 
antagonist drugs (100#M). All values are the means (_+SEM) 
nmoles of N-acetyltryptamine formed/pineal gland/hr 
(*P < 0.01 compared to vehicle:vehicle treated control values; 
eP < 0.01 compared to vehicle:xylamine treated control). 
significant changes in pineal gland NAT activity 
compared to vehicle control values (Table I). How- 
ever, each of the fl-noradrenoceptor but none of the 
~-noradrenoceptor antagonist drugs significantly at- 
tenuated the xylamine-induced elevations in pineal 
gland NAT activity. 
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rat vas deferens have been observed previously 
(Ransom et aL, 1984, 1985). Nevertheless, xylamine 
might also increase synaptic NE by other nontoxic 
mechanisms, such as by increasing release of the 
neurotransmitter from sympathetic nerve terminals 
via an amphetamine-like action on the noradrenergic 
nerve terminals that adhere to the pineal gland when 
it is placed in organ culture. 
Thus far xylamine has proven to be useful in 
examinations of the molecular mechanisms im- 
portant for neuronal NE uptake. Although its neu- 
rochemical mechanisms of action appear to differ 
significantly from some of the other noradrenergic 
reuptake inhibiting drugs available in the experi- 
mental and clinical armamentarium, it remains to be 
determined whether these mechanisms will prove 
useful as a tool for gaining a better understanding of 
the functional importance of noradrenergic neurons 
in various in vivo or in vitro preparations. 
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DISCUSSION 
Xylamine in vitro enhanced pineal gland NAT 
activity in a concentration dependent manner. This 
action of the drug is abolished in denervated glands 
and is attenuated by fl- but not ~-noradrenoceptor 
antagonist drugs. Since the abilities of neurologically 
intact pineal glands to accumulate [3H]NE are sub- 
stantially reduced by xylamine, our combined data 
suggest that xylamine elevates pineal gland NAT 
activity by increasing synaptic NE concentrations at 
pinealocyte fl-receptors via the inhibition of neuro- 
transmitter uptake into postganglionic presynaptic 
noradrenergic nerve terminals. Previous studies sug- 
gest that rat vas deferens presynaptic noradrenergic 
nerve terminals accumulate xylamine (Ransom et al., 
1985). Chemical denervation of the terminals by 
6-hydroxydopamine depletes NE content by 85% 
and reduces radiolabelled xylamine accumulation by 
70%. Since the NAT response to xylamine is also 
abolished in denervated pineal glands, it appears that 
xylamine increases pineal gland NAT activity by 
acting presynaptically on one or more noradrenergic 
neurotransmitter mechanisms. 
The NE uptake inhibiting properties of xylamine 
have been described previously in rabbit aortic rings 
(Cho et al., 1980) as well as in rat superior cervical 
ganglia (Fischer and Cho, 1982), vas deferens 
(Ransom et al., 1985) and cortical synaptosomes 
(Dudley et al., 1981). Our data indicate that xylamine 
also inhibits uptake of the neurotransmitter in 
postganglionic sympathetic terminals innervating 
the pineal gland. Nevertheless, these results do 
not rule out other possible mechanisms of action 
of xylamine. For example, xylamine and its 
chemical analogue N-(2-chloroethyl)-N-ethyl-2- 
bromobenzylamine (DSP4) appear to exert 
neurotoxic effects on peripheral and central nor- 
adrenergic nerve terminals (Dudley et al., 1981; 
Jaim-Etcheverry and Zieher, 1983), Xylamine- 
induced neurotoxic effects on peripheral cate- 
cholaminergic nerves still remain to be determined, 
however, since only marginal NE depletions in the 
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